abagovomab 36
abciximab 31
abituzumab 23
abrilumab 22
actoxumab 19
adalimumab 22
aducanumab 15
afasevikumab 21
alacizumab_pegol 13
alemtuzumab 28
alirocumab 23
amatuximab 45
andecaliximab 25
anifrolumab 23
anrukinzumab 24
aprutumab 18
aprutumab_ixadotin 18
arcitumomab 25
ascrinvacumab 8
atezolizumab 16
atinumab 16
avelumab 15
basiliximab 34
bavituximab 41
begelomab 29
benralizumab 31
bevacizumab_beta 25
bezlotoxumab 19
bimagrumab 20
bleselumab 17
blinatumomab 37
blosozumab 32
bococizumab 20
brazikumab 18
brentuximab_vedotin 37
briakinumab 20
brodalumab 16
brolucizumab 29
brontictuzumab 29
burosumab 22
cabiralizumab 29
camrelizumab 16
canakinumab 27
cantuzumab_ravtansin 48
carlumab 17
carotuximab 30
cergutuzumab_amunaleukin2 29
cergutuzumab_amunaleukin 29
certolizumab_pegol 26
cetiximab 48
citatuzumab_bogatox 29
cixutumumab 29
clivatuzumab_tetraxetan 27
codrituzumab 33
conatumumab 13
concizumab 33
crenezumab 24
crizanlizumab 29
crotedumab 21
dacetuzumab 25
daclizumab 20
dalotuzumab 39
dapirolizumab_pegol 28
daratumumab 14
dectrekumab 11
demcizumab 27
denosumab 10
depatuxizumab 24
depatuxizumab_mafodotin 24
dezamizumab 25
dinutuximab 41
diridavumab 31
domagrozumab 18
drozitumab 20
duligotuzumab 21
durvalumab 13
dusigitumab 22
efalizumab 35
efungumab 31
eldelumab 18
elezanumab 24
elgemtumab 14
elotuzumab 20
emactuzumab 23
emapalumab 26
emibetuzumab 22
enavatuzumab 26
enfortumab_vedotin 15
enoblituzumab 20
enokizumab 27
enoticumab 20
ensituximab 36
eptinezumab 20
erenumab 23
etaracizumab 18
etrolizumab 24
evinacumab 23
evolocumab 19
farletuzumab 15
fasinumab 26
fezakinumab 25
fibatuzumab 15
ficlatuzumab 25
firivumab 37
flanvotumab 21
fletikumab 28
foralumab 15
foravirumab 16
fremanezumab 31
fresolimumab 19
fulranumab 22
futuximab 33
galcanezumab 23
ganitumab 27
gantenerumab 14
gemetuzumab 34
gemtuzumab2 28
gemtuzumab 30
gevokizumab 26
girentuximab 33
glembatumumab 21
glembatumumab_vedotin 21
guselkumab 24
ibalizumab 29
ibritumomab 38
icrucumab 13
idarucizumab 40
ifabotuzumab 15
imalumab 19
imgatuzumab 24
inclacumab 21
indatuximab_ravtansin 39
indusatumab 22
inebilizumab 31
intetumumab 17
iodine_girentuximab 31
ipilimumab 7
iratumumab 16
isatuximab 40
itolizumab 28
ixekizumab 35
labetuzumab_govitecan 24
lambrolizumab 30
lampalizumab 30
lanadelumab 19
landogrozumab 19
laprituximab 30
lebrikizumab 40
lendalizumab 27
lenzilumab 20
lifastuzumab_vedotin 26
ligelizumab 25
lilotomab 43
lirilumab 25
lodelcizumab 19
lokivetmab 27
lorvotuzumab_mertansin 28
lucatumumab 30
lumretuzumab 21
lupartumab 17
lutikizumab 23
margetuximab 37
milatuzumab 44
mirvetuximab 40
mirvetuximab_soravtansin 40
modotuximab 44
mogamulizumab 36
monalizumab 22
motavizumab 38
moxetumomab_pasudotox 33
namilumab 25
naratuximab 33
naratuximab_emtansin 33
narnatumab 20
navicixizumab2 29
navicixizumab 28
navivumab 41
necitumumab 12
nemolizumab 31
nesvacumab 18
nivolumab 13
obiltoxaximab 24
obinutuzumab 36
ocaratuzumab 28
ofatumumab 20
olaratumab 19
olokizumab 28
omalizumab 20
onartuzumab 24
ontuxizumab 30
opicinumab 15
orticumab 16
otelixizumab 41
oxelumab 13
ozanezumab 35
pamrevlumab 13
panobacumab 31
parsatuzumab 29
pasotuxizumab 23
pateclizumab 20
patritumab 24
pembrolizumab 30
perakizumab 25
pidilizumab 21
pinatuzumab_vedotin 19
plozalizumab 33
pogalizumab 25
polatuzumab_vedotin 24
ponezumab 39
prezalumab 16
pritoxaximab 42
quilizumab 23
racotumomab 34
radretumab 16
ralpancizumab 23
ramucirumab 14
ranevetmab 30
ranibizumab 25
refanezumab 26
remtolumab 21
rilotumumab 22
rinucumab 20
risankizumab 37
rituximab 26
rivabazumab 24
robatumumab 20
roledumab 36
romosozumab 25
rontalizumab 24
rosmantuzumab 30
rozanolixizumab 25
sacituzumab 34
sacituzumab_govitecan 34
samalizumab 28
sapelizumab 25
sarilumab 18
secukinumab 18
seribantumab 18
setoxaximab 49
sifalimumab 13
siltuximab 25
simtuzumab 30
sirukumab 13
solanezumab 27
solitomab 31
stamulumab 19
suptavumab 28
suvizumab 24
tabalumab 13
tadocizumab 21
tamtuvetmab 34
tanezumab 24
tarextumab 13
tavolixizumab 19
telisotuzumab 31
teplizumab 26
tesidolumab 24
tezepelumab 26
tigatuzumab 18
tildrakizumab 24
timolumab 17
tisotumab 16
tosatoxumab 41
tositumomab 35
tralokinumab 29
trastuzumab 24
tregalizumab 25
trevogrumab 15
ublituximab 32
urelumab 21
ustekinumab 29
utomilumab 27
vadastuximab 28
vadastuximab_talirin 28
vandortuzumab_vedotin 20
vantictumab 22
vanucizumab2 25
vanucizumab 30
varlilumab 17
vatelizumab 22
vedolizumab 32
veltuzumab 20
vesencumab 12
vorsetuzumab 24
vorsetuzumab_mafodotin 24
vunakizumab 38
xentuzumab 20
zatuximab 44
